Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm ND: YAG laser: A comparison with surgical treatment

Kyung Goo Lee, Sun Ae Kim, Sang Min Yi, Jae Hwan Kim, Il-Hwan Kim

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Bromhidrosis is a disease presenting as malodor caused by interaction between the discharge of apocrine glands and bacteria. The main therapeutic modalities are applying topical agents, liposuction surgery, and elective surgery. Among these, elective surgery is reported to be most effective. However, the efficiency largely depends on surgical technique. Additionally, other side effects, such as hematoma and scarring, are occasionally reported. Currently, CO2 laser and 1,064 nm Nd:YAG laser therapy are used, but as the wavelength is not specific to apocrine glands, these laser therapies have certain limitations. Recently, a 1,444 nm wavelength AccusculptTM laser (LutronicCorp., Seoul, Korea) has been developed which is now commonly used for facial fat plasty and laser liposuction therapy. The use of this laser for bromhidrosis therapy targeting apocrine sweat glands is currently being discussed. Still, no studies on practical clinical use and side effects of this 1,444 nm wavelength laser have been published. In this report, we treated one bromhidrosis patient with 1,444 nm wavelength AccusculptTM laser therapy on one side while conventional surgery was performed on the other side using a modified Inaba's method. We compared the efficacy of this laser therapy to the surgical modality by measuring malodor severity and overall satisfaction by questionnaire. We also checked for other complications and recurrence for 12 months after the treatment. This patient was largely satisfied as it has a much shorter down time with the same therapeutic outcome. As subdermal coagulation treatment by 1,444 nm Nd:YAG laser may be less invasive but effective therapy, we would like to recommend this modality as a possible treatment option. (Ann Dermatol 26(1) 99∼102, 2014).

Original languageEnglish
Pages (from-to)99-102
Number of pages4
JournalAnnals of Dermatology
Volume26
Issue number1
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Solid-State Lasers
Laser Therapy
Apocrine Glands
Lipectomy
Lasers
Therapeutics
Sweat Glands
Gas Lasers
Korea
Hematoma
Cicatrix
Fats
Bacteria
Recurrence

Keywords

  • 1 444nm
  • Bromhidrosis
  • Nd:YAG
  • Subdermal coagulation

ASJC Scopus subject areas

  • Dermatology

Cite this

Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm ND : YAG laser: A comparison with surgical treatment. / Lee, Kyung Goo; Kim, Sun Ae; Yi, Sang Min; Kim, Jae Hwan; Kim, Il-Hwan.

In: Annals of Dermatology, Vol. 26, No. 1, 01.01.2014, p. 99-102.

Research output: Contribution to journalArticle

Lee, Kyung Goo ; Kim, Sun Ae ; Yi, Sang Min ; Kim, Jae Hwan ; Kim, Il-Hwan. / Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm ND : YAG laser: A comparison with surgical treatment. In: Annals of Dermatology. 2014 ; Vol. 26, No. 1. pp. 99-102.
@article{d546481a7f1b418896e426c8a97eca5a,
title = "Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm ND: YAG laser: A comparison with surgical treatment",
abstract = "Bromhidrosis is a disease presenting as malodor caused by interaction between the discharge of apocrine glands and bacteria. The main therapeutic modalities are applying topical agents, liposuction surgery, and elective surgery. Among these, elective surgery is reported to be most effective. However, the efficiency largely depends on surgical technique. Additionally, other side effects, such as hematoma and scarring, are occasionally reported. Currently, CO2 laser and 1,064 nm Nd:YAG laser therapy are used, but as the wavelength is not specific to apocrine glands, these laser therapies have certain limitations. Recently, a 1,444 nm wavelength AccusculptTM laser (LutronicCorp., Seoul, Korea) has been developed which is now commonly used for facial fat plasty and laser liposuction therapy. The use of this laser for bromhidrosis therapy targeting apocrine sweat glands is currently being discussed. Still, no studies on practical clinical use and side effects of this 1,444 nm wavelength laser have been published. In this report, we treated one bromhidrosis patient with 1,444 nm wavelength AccusculptTM laser therapy on one side while conventional surgery was performed on the other side using a modified Inaba's method. We compared the efficacy of this laser therapy to the surgical modality by measuring malodor severity and overall satisfaction by questionnaire. We also checked for other complications and recurrence for 12 months after the treatment. This patient was largely satisfied as it has a much shorter down time with the same therapeutic outcome. As subdermal coagulation treatment by 1,444 nm Nd:YAG laser may be less invasive but effective therapy, we would like to recommend this modality as a possible treatment option. (Ann Dermatol 26(1) 99∼102, 2014).",
keywords = "1 444nm, Bromhidrosis, Nd:YAG, Subdermal coagulation",
author = "Lee, {Kyung Goo} and Kim, {Sun Ae} and Yi, {Sang Min} and Kim, {Jae Hwan} and Il-Hwan Kim",
year = "2014",
month = "1",
day = "1",
doi = "10.5021/ad.2014.26.1.99",
language = "English",
volume = "26",
pages = "99--102",
journal = "Annals of Dermatology",
issn = "1013-9087",
publisher = "Korean Dermatological Association",
number = "1",

}

TY - JOUR

T1 - Subdermal coagulation treatment of axillary bromhidrosis by 1,444 nm ND

T2 - YAG laser: A comparison with surgical treatment

AU - Lee, Kyung Goo

AU - Kim, Sun Ae

AU - Yi, Sang Min

AU - Kim, Jae Hwan

AU - Kim, Il-Hwan

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Bromhidrosis is a disease presenting as malodor caused by interaction between the discharge of apocrine glands and bacteria. The main therapeutic modalities are applying topical agents, liposuction surgery, and elective surgery. Among these, elective surgery is reported to be most effective. However, the efficiency largely depends on surgical technique. Additionally, other side effects, such as hematoma and scarring, are occasionally reported. Currently, CO2 laser and 1,064 nm Nd:YAG laser therapy are used, but as the wavelength is not specific to apocrine glands, these laser therapies have certain limitations. Recently, a 1,444 nm wavelength AccusculptTM laser (LutronicCorp., Seoul, Korea) has been developed which is now commonly used for facial fat plasty and laser liposuction therapy. The use of this laser for bromhidrosis therapy targeting apocrine sweat glands is currently being discussed. Still, no studies on practical clinical use and side effects of this 1,444 nm wavelength laser have been published. In this report, we treated one bromhidrosis patient with 1,444 nm wavelength AccusculptTM laser therapy on one side while conventional surgery was performed on the other side using a modified Inaba's method. We compared the efficacy of this laser therapy to the surgical modality by measuring malodor severity and overall satisfaction by questionnaire. We also checked for other complications and recurrence for 12 months after the treatment. This patient was largely satisfied as it has a much shorter down time with the same therapeutic outcome. As subdermal coagulation treatment by 1,444 nm Nd:YAG laser may be less invasive but effective therapy, we would like to recommend this modality as a possible treatment option. (Ann Dermatol 26(1) 99∼102, 2014).

AB - Bromhidrosis is a disease presenting as malodor caused by interaction between the discharge of apocrine glands and bacteria. The main therapeutic modalities are applying topical agents, liposuction surgery, and elective surgery. Among these, elective surgery is reported to be most effective. However, the efficiency largely depends on surgical technique. Additionally, other side effects, such as hematoma and scarring, are occasionally reported. Currently, CO2 laser and 1,064 nm Nd:YAG laser therapy are used, but as the wavelength is not specific to apocrine glands, these laser therapies have certain limitations. Recently, a 1,444 nm wavelength AccusculptTM laser (LutronicCorp., Seoul, Korea) has been developed which is now commonly used for facial fat plasty and laser liposuction therapy. The use of this laser for bromhidrosis therapy targeting apocrine sweat glands is currently being discussed. Still, no studies on practical clinical use and side effects of this 1,444 nm wavelength laser have been published. In this report, we treated one bromhidrosis patient with 1,444 nm wavelength AccusculptTM laser therapy on one side while conventional surgery was performed on the other side using a modified Inaba's method. We compared the efficacy of this laser therapy to the surgical modality by measuring malodor severity and overall satisfaction by questionnaire. We also checked for other complications and recurrence for 12 months after the treatment. This patient was largely satisfied as it has a much shorter down time with the same therapeutic outcome. As subdermal coagulation treatment by 1,444 nm Nd:YAG laser may be less invasive but effective therapy, we would like to recommend this modality as a possible treatment option. (Ann Dermatol 26(1) 99∼102, 2014).

KW - 1 444nm

KW - Bromhidrosis

KW - Nd:YAG

KW - Subdermal coagulation

UR - http://www.scopus.com/inward/record.url?scp=84901812597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901812597&partnerID=8YFLogxK

U2 - 10.5021/ad.2014.26.1.99

DO - 10.5021/ad.2014.26.1.99

M3 - Article

AN - SCOPUS:84901812597

VL - 26

SP - 99

EP - 102

JO - Annals of Dermatology

JF - Annals of Dermatology

SN - 1013-9087

IS - 1

ER -